ClinicalTrials.gg
RecruitingNCT07698366Updated Sep 28, 2026

Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized Trial

An interventional study of Standardized Breast Ultrasound Screening in Breast Neoplasms and Early Detection of Cancer, sponsored by The First Affiliated Hospital with Nanjing Medical University. Recruiting at 2 sites in China. Open to female participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by The First Affiliated Hospital with Nanjing Medical University · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Sep 28, 2026Now RecruitingSite recruiting status changed+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80,000
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 57 studies in Breast Neoplasms by The First Affiliated Hospital with Nanjing Medical University — 39 open to participants now, 40 under way, none of them phase 3. Breast Neoplasms · The First Affiliated Hospital with Nanjing Medical University.

Planned enrollment
Largest of 44
80,000 · median 76
Started
2026
with 9 others
No phase
15 of 57
12 open now
Primary completion
2029-09
later than 35 of 39 live
Registered
53rd of 57
by date

Among the 57 studies in Breast Neoplasms by The First Affiliated Hospital with Nanjing Medical University, this one has the largest planned enrollment of the 44 interventional ones that give a count, is one of 10 that started in 2026, is one of 15 with no phase, reaches primary completion later than 35 of the 39 other live ones, and was the 53rd registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

39 of the 57 studies in Breast Neoplasms by The First Affiliated Hospital with Nanjing Medical University are open now, in 1 country. Recruiting first, the newest first:

33 more — sign in →

By country, each count listing its studies:

All 39 open studies →

Where they have run

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 65 Years to 80 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Breast Neoplasms by The First Affiliated Hospital with Nanjing Medical University, or all of them as a file.
02

Study summary

This multicenter, cluster randomized trial will evaluate whether community-based breast ultrasound screening improves the early detection of breast cancer in women aged 65 to 80 years, compared with routine health management. Approximately 80,000 women in Jiangsu Province, China, will be enrolled and followed for breast cancer outcomes.

Read the detailed description

This is a multicenter, open-label, cluster randomized controlled trial in Jiangsu Province, China. Approximately 80,000 women aged 65 to 80 years will be enrolled. Participating community health service stations will be assigned to either active breast ultrasound screening or routine health management. Women in the screening group will receive a standardized breast ultrasound examination, while those in the control group will receive no additional study-specific breast screening. The primary outcome is the difference between groups in the proportion of diagnosed breast cancers that are stage I or II during 24 months of follow-up. The study will also assess other screening-related and implementation outcomes.

03

Conditions studied

  • Breast Neoplasms
  • Early Detection of Cancer

Browse trials for

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged 65-80 years.
  • Local residents living in participating communities for ≥6 months.
  • Signed and willingness to participate.

Exclusion criteria

Exclusion Criteria:

  • History of breast cancer or previous breast cancer treatment.
  • Breast cancer screening within the past 2 years.
  • Severe comorbid conditions that may affect study participation or follow-up.
  • Acute breast disease or conditions requiring immediate treatment.
  • Unable to cooperate with screening procedures due to physical or cognitive limitations.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80,000 participants (estimated)

Study arms

  • Experimental
    Ultrasound Active Screening Group

    Participants assigned to this group through their community health service station receive one standardized breast ultrasound examination performed by a qualified physician. Abnormal findings are managed according to routine clinical practice.

    Diagnostic Test: Standardized Breast Ultrasound Screening

  • No intervention
    Routine Health Management Group

    Participants receive conventional community health management and annual physical examination according to local routine practice, without study-specific breast ultrasound screening.

Interventions

  • Diagnostic testStandardized Breast Ultrasound Screening

    One standardized breast ultrasound examination performed and interpreted by a qualified physician, with further clinical evaluation of abnormal findings as appropriate.

06

What researchers measure

Primary outcomes

  1. Absolute difference in early-stage breast cancer diagnosis rate

    The between-group absolute difference in the proportion of pathologically confirmed breast cancer cases diagnosed at stage I or II.

    Time frame: 24 months after enrollment

Secondary outcomes

  1. Overall breast cancer detection rate

    The proportion of participants diagnosed with breast cancer in each group during follow-up.

    Time frame: 24 months

  2. Late-stage breast cancer diagnosis rate

    The proportion of participants diagnosed with stage III or IV breast cancer in each group.

    Time frame: Up to 24 months after enrollment

  3. Breast biopsy rate

    The proportion of participants undergoing a breast biopsy in each group during follow-up.

    Time frame: Up to 24 months after enrollment

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because there is currently no approved data sharing policy for this multicenter study. De-identified participant data will be managed in accordance with institutional regulations and applicable ethical and legal requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Sep 2029, 36 months after the start.

Of 2,673 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 36 months is close to that.

Counting every sponsor, half of 2,783 studies reached it within 33 months; a quarter within 15 and three quarters within 66.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 28, 2026: start Jul 2026 → Sep 2026 and primary completion Jul 2029 → Sep 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Jul 13, 2026
StartActual
Sep 20, 2026was Jul 2026
Primary completionEst.
Sep 20, 2029was Jul 2029
CompletionEst.
Dec 31, 2029
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Sep 28, 2026
Sites
1 site added. Kunshan First People's Hospital is now Recruiting
Show site
  • The Fourth Affiliated Hospital of Nanjing Medical University · Nanjing, China
Sep 28, 2026
Start date
Jul 10, 2026→Sep 20, 2026 (actual)
Sep 28, 2026
Primary completion
Jul 10, 2029→Sep 20, 2029
Sep 28, 2026
Enrollment
82440→80000
Sep 28, 2026
Interventions
Added Diagnostic test: Standardized Breast Ultrasound Screening; removed Procedure: Standardized Breast Ultrasound Screening
Sep 28, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionAbsolute difference in early-stage breast cancer diagnosis rate: how it is measured was reworded
Sep 28, 2026
Secondary outcomes
2 added, 1 description edited
What changed in the outcomes
  • AddedLate-stage breast cancer diagnosis rateTime frame: Up to 24 months after enrollment
  • AddedBreast biopsy rateTime frame: Up to 24 months after enrollment
  • DescriptionOverall breast cancer detection rate: how it is measured was reworded
Sep 28, 2026
Title
Breast Ultrasound Screening for Early Detection of Breast Cancer in Elderly Women: A MixedMulticenter Cluster-Individual RCT Randomized Trial
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    Not yet recruiting→Recruiting
    1 site added. Kunshan First People's Hospital is now Recruiting
    Show site
    • The Fourth Affiliated Hospital of Nanjing Medical University · Nanjing, China
    Start date Jul 10, 2026→Sep 20, 2026 (now actual)
    Primary completion Jul 10, 2029→Sep 20, 2029
    Enrollment 82440→80000
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionAbsolute difference in early-stage breast cancer diagnosis rate: how it is measured was reworded
    Secondary outcomes 2 added, 1 description edited
    What changed in the outcomes
    • AddedLate-stage breast cancer diagnosis rateTime frame: Up to 24 months after enrollment
    • AddedBreast biopsy rateTime frame: Up to 24 months after enrollment
    • DescriptionOverall breast cancer detection rate: how it is measured was reworded
    Interventions Added Diagnostic test: Standardized Breast Ultrasound Screening; removed Procedure: Standardized Breast Ultrasound Screening
    Title Breast Ultrasound Screening for Early Detection of Breast Cancer in Elderly Women: A MixedMulticenter Cluster-Individual RCT Randomized Trial
    + 3 other changes: verification date, responsible party and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07698366
Responsible party
Sponsor
First posted
Jul 13, 2026
Start date
Sep 20, 2026
Primary completion
Sep 20, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Sep 28, 2026

Study contacts

Ge Ma, doctor
Contact
ntmage@sina.com
+8618262632870

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion